recombinant human papillomavirus vaccine Injection 0.5 ml

Established in 2001, this manufacturer employs approximately 2,388 individuals and specializes in the research, development, production, and distribution of vaccines. As a CTD dossier owner and manufacturer, it holds GMP approvals from multiple countries, ensuring compliance with international quality standards. The manufacturer operates advanced production lines for various vaccines, adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed in over 20 countries worldwide.